Pentokey Organy
35.50
-0.07(-0.20%)
Market Cap₹22.26 Cr
PE Ratio82.72
IndustryChemicals
Company Performance:
1D-0.20%
1M+4.44%
6M-8.95%
1Y-27.55%
5Y0.00%
View Company Insightsright
More news about Pentokey Organy
13Aug 26
Pentokey Organy Q1 Results: Net Profit Falls 55% To ₹21.73 Lakh
Pentokey Organy's Q1FY27 results show a 55% YoY profit decline to ₹21.73 lakh amid zero operational revenue. Other income rose to ₹8.34 lakh, while negative expenses of ₹13.39 lakh supported the bottom line. Full-year FY26 profit was ₹20.32 lakh.
 no imag found
26May 26
Pentokey board to consider Q4FY26 results on May 30
Pentokey Organy (India) Limited will hold a board meeting on May 30, 2026, to approve audited financial results for Q4 and FY26. The trading window will reopen 48 hours post-results announcement.
 no imag found
15Apr 26
Pentokey Organy (India) Limited Files SEBI Compliance Certificate for Q4FY26
Pentokey Organy (India) Limited filed its Q4FY26 compliance certificate under SEBI Regulation 74(5), reporting 883 shares dematerialized across both depositories with zero rematerializations. The certificate, submitted through registrar Datamatics Business Solutions Ltd, confirms proper processing of all share transfers and adherence to regulatory requirements for the quarter ended 31st March, 2026.
 no imag found
16Jan 26
Pentokey Organy Board Meeting Scheduled for January 21, 2026 to Review Q3FY26 Financial Results
Pentokey Organy (India) Limited has scheduled a board meeting for January 21, 2026, to consider and approve unaudited financial results for Q3FY26 ended December 31, 2025. The company informed BSE about the meeting in compliance with SEBI regulations. The trading window for company securities, currently closed under insider trading regulations, will reopen 48 hours after the financial results become publicly available.
 no imag found
08Nov 25
Pentokey Organy Reports Robust Q2 FY26 Performance with 347% Revenue Growth
Pentokey Organy Limited, operating in the Pharma/Pesticides trading segment, announced impressive Q2 FY26 results. Revenue from operations soared 346.95% to Rs. 98.33 lakhs, while total income rose 195.47% to Rs. 108.94 lakhs. Net profit increased by 35.14% to Rs. 14.23 lakhs, with EPS reaching Rs. 0.23. The company's half-year revenue for FY26 stood at Rs. 604.54 lakhs, up from Rs. 22.09 lakhs in the previous year. An unmodified limited review report was issued by the statutory auditors. The company has a pending income tax appeal for Rs. 171.58 lakhs for the assessment year 2015-16.
 no imag found
Pentokey Organy
35.50
-0.07
(-0.20%)
1 Year Returns:-27.55%
Industry Peers
Tata Chemicals
589.75
(-0.54%)
TANFAC Industries
3,148.00
(-0.88%)
Grauer & Weil
81.32
(+4.26%)
GHCL
386.25
(-0.46%)
Chemplast Sanmar
214.68
(+1.08%)
JG Chemicals
630.75
(-1.24%)